This fall, Health Canada is anticipating sharing a policy consultation document about health products containing (CBD). This proposal has been in the works since 2019.
In 2022, Health Canada released a report on health products containing cannabis.
Health products containing cannabidiol that would not require practitioner oversight will get a new regulatory pathway created by Health Canada as indicated in their Forward Regulatory Plan: 2024-2026.
New amendments created
In June of 2021, to better protect young people, Health Canada consulted with the public on proposed amendments to the Cannabis Regulations. These amendments would restrict inhaled cannabis extracts with certain flavours, other than the flavour of cannabis itself. These restrictions apply to producing, selling, promoting, packaging and/or labelling the products.
Health Canada initiated a legislative review of the Cannabis Act, after publishing these proposed amendments. Stakeholders identified a number of issues and concerns with the regulation of cannabis products as noted in the Expert Panel’s what we heard report. A final report to the Minister of Health, and the Minister of Mental Health and Addictions and Associate Minister of Health. This report was tabled in both Houses of Parliament on March 22, 2024.
Final recommendations are currently being examined before determining how to proceed with any further restrictions on flavours in cannabis extracts.
Potential impacts:
Licensed processors, medical sale licence holders and provincially or territorially authorized retailers could be impacted by these new proposed amendments. As a result, licence holders will be required to produce and sell cannabis products in compliance with the new requirements.
How can you proceed? Get assisted by Cannabis License Experts
For detailed insights into these regulatory changes and ongoing consultations, reach out to our team of former Health Canada experts at Cannabis License Experts. We help ensure compliance with modernized regulations governing health products containing cannabis (CBD), natural health products (NHPs) and non-prescription drugs, enhancing safety and quality standards across Canada while facilitating business growth and innovation.
In 2022, Health Canada released a report on health products containing cannabis.
Health products containing cannabidiol that would not require practitioner oversight will get a new regulatory pathway created by Health Canada as indicated in their Forward Regulatory Plan: 2024-2026.
New amendments created
In June of 2021, to better protect young people, Health Canada consulted with the public on proposed amendments to the Cannabis Regulations. These amendments would restrict inhaled cannabis extracts with certain flavours, other than the flavour of cannabis itself. These restrictions apply to producing, selling, promoting, packaging and/or labelling the products.
Health Canada initiated a legislative review of the Cannabis Act, after publishing these proposed amendments. Stakeholders identified a number of issues and concerns with the regulation of cannabis products as noted in the Expert Panel’s what we heard report. A final report to the Minister of Health, and the Minister of Mental Health and Addictions and Associate Minister of Health. This report was tabled in both Houses of Parliament on March 22, 2024.
Final recommendations are currently being examined before determining how to proceed with any further restrictions on flavours in cannabis extracts.
Potential impacts:
Licensed processors, medical sale licence holders and provincially or territorially authorized retailers could be impacted by these new proposed amendments. As a result, licence holders will be required to produce and sell cannabis products in compliance with the new requirements.
How can you proceed? Get assisted by Cannabis License Experts
For detailed insights into these regulatory changes and ongoing consultations, reach out to our team of former Health Canada experts at Cannabis License Experts. We help ensure compliance with modernized regulations governing health products containing cannabis (CBD), natural health products (NHPs) and non-prescription drugs, enhancing safety and quality standards across Canada while facilitating business growth and innovation.
